InvestorsHub Logo
Followers 53
Posts 1782
Boards Moderated 0
Alias Born 03/22/2015

Re: HGilS post# 363901

Thursday, 12/30/2021 2:41:10 PM

Thursday, December 30, 2021 2:41:10 PM

Post# of 402513

PROZAC Generic!!! Hey the table needs to be updated with Fluoxetine capsules launched in June.

From the transcript:

So 2022 we have a product under review with FDA. We have a licensed product co-developed with a partner that we are expecting approval in the first half of this coming year 2022. For our commercial products, Fluoxetine capsules are launched in June and they are marketed by Cresco under their Burrell Pharmaceutical label. Fluoxetine continues to be on the FDAs product shortage list. And we are expecting further growth from this product.








Lol Cresco is a Canadian weed company and Burrell is a family pharmacy in Missouri. Neither of them owns an ANDA for fluoxetine, nor does Elite. This statement is very obviously referring to loxapine marketed in June by Prasco and Burel and still on the FDA shortage list. Good grief, ever hear of due diligence? Let's put in a little effort before posting.




#FreeSequestOx


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News